No doubt about that @TheAnalyst007 & interesting to compart EYE with OPT, laser vs drug intervention for AMD, admittedly OPT Opthea are targeting a 'cure' for late stage wet AMD vs EYE trying to prevent the progression to advanced wet AMD in the first place, so a different target market & less super expressive ongoing drug treatment.
BUT market cap comparison is interesting:
EYE MC A$50 Mil - A$30 Mil in cash in the bank, no debt = EV approx A$20 Mil !! ,revenue A$6.644,000 loss (A$1,605,000) as at Feb 2021 half yr report
OPT MC A$500 Mil - A$202,544,985 cash, no debt = EV approx A$300 Mil ,revenue A$314,294 loss (A$34,982,213) as at Feb 2021 half yr report
So roughly OPT chasing the same market with no revenue like iTrack business, has MC approx 15x greater than EYE
EYE has some room to move up IMO !!
.
No doubt about that @TheAnalyst007 & interesting to compart EYE...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.005(1.85%) |
Mkt cap ! $62.91M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.5¢ | 26.5¢ | $40.17K | 150.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 43000 | 1 |
View Market Depth
| Last trade - 15.35pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
27.0¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 26.5¢ | 27.0¢ | 26.5¢ | 19422 | ||
| Last updated 15.04pm 26/04/2024 ? | |||||
| EYE (ASX) Chart |